Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.59 |
| ▸ | NOX1 | Q9Y5S8 | 4/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | BCHE | P06276 | 4/20 | 0.51 |
| ▸ | HRH1 | P35367 | 3/20 | 0.51 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.51 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.51 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | HTR2C | P28335 | 2/20 | 0.49 |
| ▸ | HTR2B | P41595 | 2/20 | 0.49 |
| ▸ | HTR6 | P50406 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | ACHE | P22303 | 2/20 | 0.49 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Metiazinic Acid SCHEMBL10820947 | 1.00 | LMNA (0.59) | LMNANOX1L3MBTL1MAPTMAPK1 | |
| Metiazinic Acid SCHEMBL30190433 | 1.00 | LMNA (0.59) | LMNANOX1L3MBTL1MAPTMAPK1 | |
| Metiazinic Acid SCHEMBL30697757 | 1.00 | LMNA (0.59) | LMNANOX1L3MBTL1MAPTMAPK1 | |
| SCHEMBL28555924 | 0.86 | NOX1 (0.57) | LMNANOX1L3MBTL1MAPTMAPK1 | |
| SCHEMBL2669592 | 0.86 | MAOA (0.54) | LMNANOX1L3MBTL1MAPTMAPK1 | |
| SCHEMBL6850282 | 0.85 | MAPT (0.56) | LMNANOX1L3MBTL1MAPTMAPK1 | |
| SCHEMBL13295825 | 0.83 | BCHE (0.53) | LMNANOX1L3MBTL1MAPTMAPK1 | |
| SCHEMBL15101212 | 0.82 | MAPT (0.52) | LMNANOX1L3MBTL1MAPTMAPK1 | |
| Metiazinic Acid SCHEMBL7627349 | 0.81 | LMNA (0.54) | LMNANOX1L3MBTL1MAPTMAPK1 | |
| Metiazinic Acid SCHEMBL8208232 | 0.81 | MAPT (0.56) | LMNANOX1L3MBTL1MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3381 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4628080-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF DRUG-RELATED PEPTIC ULCER COMPRISING ZASTAPRAZAN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Jeil Pharmaceutical Co., Ltd. (KR) | 2025-10-08 | — | — | EP | claimed |
| EP-4470565-A1 | METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT | OnQuality Pharmaceuticals China Ltd. (CN) | 2024-12-04 | — | — | EP | claimed |
| CN-118742325-A | Methods for preventing or treating diseases or conditions associated with antineoplastic agents | 上海岸阔医药科技有限公司 | 2024-10-01 | — | — | CN | claimed |
| WO-2024117797-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF DRUG-RELATED PEPTIC ULCER COMPRISING ZASTAPRAZAN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 제일약품 주식회사 | 2024-06-06 | — | — | WO | claimed |
| WO-2024105529-A1 | CHEMICAL DISBUDDING OF LIVESTOCK | MASSEY UNIVERSITY (NZ) | 2024-05-23 | — | — | WO | claimed |
| US-20240041935-A1 | PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS | CREATIVE MEDICAL TECHNOLOGIES, INC. (US) | 2024-02-08 | — | — | US | claimed |
| EP-3752201-B1 | SUSPENSION OF NANOSCALE, ORGANIC PARTICLES AND PROCESS FOR PRODUCTION THEREOF | UNIV FRIEDRICH ALEXANDER ER (DE) | 2023-11-22 | — | — | EP | claimed |
| WO-2023142996-A1 | METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT | 上海岸阔医药科技有限公司 | 2023-08-03 | — | — | WO | claimed |
| EP-4034087-A1 | LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS | DDS Research Inc. (CA) | 2022-08-03 | — | — | EP | claimed |
| US-20220218611-A1 | LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS | DDS RESEARCH INC. (CA) | 2022-07-14 | — | — | US | claimed |
| EP-0569411-B1 | ACYLAMINO-ALKYLIDEN-HYDROXY-BISPHOSPHONIC ACIDS USEFUL IN THE THERAPY OF OSTEOARTICULAR DISEASES | GENTILI IST SPA (IT) | 1995-03-29 | — | — | EP | claimed |
| US-5330981-A | Antiinflammatory agents | ISTITUTO GENTILI S.P.A. (IT) | 1994-07-19 | — | — | US | claimed |
| EP-0569411-A1 | ACYLAMINO-ALKYLIDEN-HYDROXY-BISPHOSPHONIC ACIDS USEFUL IN THE THERAPY OF OSTEOARTICULAR DISEASES. | GENTILI IST SPA (IT) | 1993-11-18 | — | — | EP | claimed |
| EP-0537313-A1 | ARYLALKYL ESTERS OF 4,5-DIHYDROXY-9,10-DIHYDRO-9,10-DIOXO-2-ANTHRACENECARBOXYLIC ACID HAVING THERAPEUTICAL ACTIVITY. | GENTILI IST SPA (IT) | 1993-04-21 | — | — | EP | claimed |
| WO-1992019584-A1 | ARYLALKYL ESTERS OF 4,5-DIHYDROXY-9,10-DIHYDRO-9,10-DIOXO-2-ANTHRACENECARBOXYLIC ACID HAVING THERAPEUTICAL ACTIVITY | ISTITUTO GENTILI S.P.A. (IT) | 1992-11-12 | — | — | WO | claimed |
| WO-1992013864-A1 | ACYLAMINO-ALKYLIDEN-HYDROXY-BISPHOSPHONIC ACIDS USEFUL IN THE THERAPY OF OSTEOARTICULAR DISEASES | ISTITUTO GENTILI S.P.A. (IT) | 1992-08-20 | — | — | WO | claimed |
| EP-0040899-B1 | METHOD OF DELIVERING DRUG WITH AID OF EFFERVESCENT ACTIVITY GENERATED IN ENVIRONMENT OF USE | ALZA CORPORATION (US) | 1984-09-12 | — | — | EP | claimed |
| EP-0072462-A2 | Pharmaceutical preparations | Toko Yakuhin Industry Co., Ltd. (JP) | 1983-02-23 | — | — | EP | claimed |
| US-4344929-A | Method of delivering drug with aid of effervescent activity generated in environment of use | ALZA CORPORATION (US) | 1982-08-17 | — | — | US | claimed |
| EP-0040899-A2 | Method of delivering drug with aid of effervescent activity generated in environment of use | ALZA CORPORATION (US) | 1981-12-02 | — | — | EP | claimed |